In a report released on March 10, Saurabh Pant from Bank of America Securities maintained a Buy rating on Patterson-UTI (PTEN – Research Report). The company’s shares closed yesterday at $7.80.

Researchers from the University of Colorado Anschutz Medical Campus studied a new method to deliver antibiotics, specifically gentamicin, directly into the bladder tissue to better treat UTIs.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...

ATLANTA, March 13, 2025 /PRNewswire/ -- Chicken Salad Chick, the nation's only fast casual chicken salad restaurant concept, announced today the opening of its 37 th restaurant in Texas, located ...

A recent study highlights how shift work, sleep debt, and night shifts increase the risk of infections among nurses, particularly the common cold. Study: Night work and sleep debt are associated ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...

After hours: March 14 at 7:28:39 PM EDT Loading Chart for PTEN ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

1. Current NAV: The Current Net Asset Value of the UTI Nifty 50 Index Fund - Direct Plan as of Mar 17, 2025 is Rs 155.93 for Growth option of its Direct plan. 2. Returns: Its trailing returns over ...

1. Current NAV: The Current Net Asset Value of the UTI Small Cap Fund - Regular Plan as of Mar 13, 2025 is Rs 21.82 for Growth option of its Regular plan. 2. Returns: Its trailing returns over ...